Pazopanib hydrochloride
5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride
Molecular Identity
Pazopanib hydrochloride
5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride
PubChem CID: 11525740
Pazopanib hydrochloride is a hydrochloride salt prepared from equimolar amounts of pazopanib and hydrochloric acid. Used for treatment of kidney cancer. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor, an angiogenesis modulating agent and a vascular endothelial growth factor receptor antagonist. It contains a pazopanib(1+).
2D Structure
Properties
C21H24ClN7O2S
Molecular Formula
474.00
Molecular Weight
g/mol
473.1401
Exact Mass
Da
127
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
8
H-Bond Acceptors
717
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Pazopanib hydrochloride635702-64-6pazopanib HClUNII-33Y9ANM545pazopanib monohydrochloridePazopanib (as hydrochloride)5-((4-((2,3-DIMETHYL-2H-INDAZOL-6-YL)(METHYL)AMINO)PYRIMIDIN-2-YL)AMINO)-2-METHYLBENZENESULFONAMIDE HYDROCHLORIDE33Y9ANM545CHEBI:71217DTXSID70212956NSC7377545-((4-((2,3-Dimethyl-2H-indazol-6-yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochlorideBenzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-, monohydrochloridePAZOPANIB HYDROCHLORIDE (MART.)PAZOPANIB HYDROCHLORIDE [MART.]
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Pazopanib hydrochloride
Loading drug network...